Multiparametric MRI-based radiomics analysis for the prediction of breast tumor regression patterns after neoadjuvant chemotherapy.

CONCLUSIONS: Our study established a unique model combining a radiomic signature and clinicopathological factors to predict tumor regression patterns prior to the initiation of NAC. The early prediction of type 2 regression offers the opportunity to modify preoperative treatments or aids in determining surgical options. PMID: 32759037 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32759037?dopt=Abstract

Source: Translational Oncology - August 2, 2020 Category: Cancer & Oncology Authors: Zhuang X, Chen C, Liu Z, Zhang L, Zhou X, Cheng M, Ji F, Zhu T, Lei C, Zhang J, Jiang J, Tian J, Wang K Tags: Transl Oncol Source Type: research